Trials / Terminated
TerminatedNCT02339987
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Saint John's Cancer Institute · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)
Detailed description
The purpose of this study is to allow the collection of tissue from subjects to be used in future research studies by scientists and to isolate tumor fighting cells for the future treatment of Melanoma.
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2018-06-04
- Completion
- 2018-06-04
- First posted
- 2015-01-16
- Last updated
- 2019-02-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02339987. Inclusion in this directory is not an endorsement.